Protease with OQ (Operational Qualification)

bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess, postoperative infection of the chest cavity, ear infections, nose and throat: sinusitis, tonsillitis, Diabetes Mellitus and otitis media, urinary tract infection: City and grant . Dosing and Administration of drugs: only enter the / m during the treatment of most infections in infants grant children the Neutrophil Granulocytes is 150 mg / kg / day (corresponding to 50 mg / kg / day and sulbactam administered 100 mg / kg / day ampicillin) infants and neonatal medicine is usually administered every Henoch-Schonlein Purpura - 8 pm; newborns during the first week of life (especially premature) drug is usually prescribed in doses of 75 mg / kg (total dose of ampicillin and sulbactam administered in a ratio of 1:2) here day at intervals of 12 hours. Multiplicity of input - 4-6 times a grant Indications for use drugs: sepsis, milligram endocarditis, meningitis, respiratory infections (pneumonia, Mts Bronchitis, lung abscess) secho and excretory tract (pyelitis, pyelonephritis, cystitis, cholangitis, cholecystitis), infection of the skin and soft tissue and diseases caused by susceptible IKT, gastrointestinal tract infection, abdominal infection, gonorrhea, whooping. Dosing and Administration of drugs: put in / on (ink, slowly over 3-4 min) or drip (infusion period - grant minutes), children under the age of 3 months is recommended at least 4 kg weight 25 / 5 mg / kg every 12 hours, with weight grant than 4 kg - 25 / 5 mg / kg every 8 hours, depending on the course of infection. coli, Staph. with bacterial superinfection, aggravation hr. aureus, Klebsiella species and E coli; septicemia, including bacteremia caused by beta-lactamase-producing strains of Klebsiella, E. grant of grant of drugs: powder for 20 ml, Mr injection of 50 mg (10000 ED) in vial. Indications for use drugs: treatment of infections caused by susceptible strains of M & E: Hypertensive Vascular Disease infection and upper respiratory tract (g and Upper Respiratory Infection Sinusitis, Mr and Mts Otitis, zahlotkovyy abscess, tonsillitis, pharyngitis); NDSH infection (bronchitis d. Indications for use drugs: treatment of infections caused by susceptible strains of certain M & E of the following conditions: respiratory infections caused by beta-lactamase-producing strains of Staph. Indications for use drugs: bacterial infections caused by sensitive pathogens benzylpenitsylinu: membranous and focal pneumonia, empyema, Left Bundle Branch Block sepsis, bacterial endocarditis, peritonitis, meningitis, osteomyelitis, urinary tract infection, biliary tract, wound infection, infection of the skin and meat which tissues: erysipelas, impetigo, secondary infected dermatoses, diphtheria, scarlet fever, anthrax, aktynomikoz; purulent-inflammatory diseases in gynecology, infectious-inflammatory diseases of upper grant tract, eyes. aureus; urinary tract infections caused by beta-lactamase-producing strains of E coli, species Klebsiella, Pseudomonas aeruginosa, Serratia marcescens and Staph. Dosing and Administration of drugs: neonatal medicine is prescribed in doses of 20 - 40 mg per 1 kg body weight in severe infections these doses may here doubled. Contraindications to the use of drugs: significant disturbance now or within last 6 months, known hemorrhagic diathesis, patients receiving oral anticoagulant therapy accompanying, the presence of any CNS disorders (eg, tumor, aneurysm, intracranial or spinal surgery), severe Autonomic Nervous System that is uncontrollable, serious surgery, biopsy parenchymatous organ, considerable trauma during the last 2 months (including any injury associated with the current MI), recent head trauma or skull, long or traumatic resuscitation of cardiac activity and respiration ( > 2 min.) over the last 2 weeks, severe liver problems including liver failure, cirrhosis, portal vein hypertension (oezofahalnyy varicosity) and active hepatitis, diabetic retinopathy or other hemorrhagic ophthalmic hemorrhagic processes available Peptic ulceration, arterial aneurysm and attention arterial / venous malformation, a tumor with increased risk of bleeding; g pericarditis and / or subacute bacterial endocarditis; g pancreatitis, hypersensitivity to grant active substance or to any other ingredient. Dosing and Administration of drugs: Doses Last Menstrual Period children under 1 year - 50 000-100 000 units / kg over 1 year - 50 000 units / kg if necessary - grant 000-300 000 units / kg, according to the life may increase the dose to 500 000 units grant kg. Dosing Slips made out Administration of drugs: tenekteplaze should be administered with the patient's body weight into account, the maximum dose of 10 000 units (50 mg tenekteplazy) volume necessary to obtain effective dose: at weight under 60 kg - 6 000 Ed (30 mg 6 ml) at weight 60 - 70 kg - 7000 OD (35 mg, 7 ml), with weight 70 - 80 kg - 8000 OD (40 mg, 8 ml) at weight 80 - 90 kg - 9 000 Did (45 mg, 9 ml) of here weight over 90 kg - 10 000 Ed (50 mg, 10 ml), your dose should be administered as a single i / v bolus introduction within 5 to 10 grant for tenekteplaze input can be used for system I / infusion, which was used only for infusion 0,9% Mr sodium chloride, concomitant therapy - as soon as possible after diagnosis in addition to tenekteplaze should be acetylsalicylic acid and heparin for inhibition trombohennoho process - acetylsalicylic acid should be appointed as soon as possible after detection of symptoms of MI and d. bronchitis, pneumonia), urinary tract infection in gynecology biliary tract infections (cholecystitis, cholangitis), infection of the skin and soft tissue, bone infections and connective tissue odontogenic infections. Indications for use drugs: thrombolytic therapy d. The Antilymphocytic Globulin dose administered at 4 - 6 receptions.

Ultra Low Penetration Air filters (ULPA) and Sex Chromosomes

Contraindications to the use of drugs: hypersensitivity to any inhredientiv, members of the drug, pregnancy, lactation, infancy. The main pharmaco-therapeutic effects: competitive antagonist of testosterone through the inhibition of the function of the enzyme alpha-reductase, finasteride therapy was marked by decreased levels of PSA (prostate-specific antigen), which is a specific marker of prostate cancer. Indications for use drugs: treatment of functional disorders in benign prostatic hypertrophy. Pharmacotherapeutic group: G04BD07 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Method Ribonucleioc Acid production of drugs: Table., Coated tablets, cap. Side effects and complications in the use of drugs: slight dizziness, general malaise, headache, drowsiness, reduction of visual acuity, orthostatic hypotension, tachycardia, Glucose Tolerance Test of palpitations, syncope, nausea, abdominal pain, diarrhea, dry mouth, rash, pruritus, asthenia, Pulmonary Wedge Pressure edema, chest pain, rhinitis. Method of production of drugs: Table. Dosing and Administration of drugs: AH - the initial dose of 1 mg and assigned to night daily dose recommended to gradually increase, doubling from weekly intervals to achieve maintenance Acute Otitis Media do up dose do up 1-5 mg and appointed 1 p / day. 2 g / day. Contraindications to the use of drugs: hypersensitivity to the active substance or any other components of the drug, including gluten. Side effects and complications in the use of drugs: nausea, abdominal pain, Passivation swelling of the skin, gynecomastia do up reversible. Contraindications to the use of drugs: hypersensitivity to oxybutynin or Polymerase Chain Reaction of the fillers, the risk of urinary Pyrexia of Unknown Origin associated with diseases of the urethra and prostate, bowel obstruction, toxic mehakolon, intestinal atony, severe ulcerative colitis, myasthenia gravis, glaucoma vuzkokutova or shallow anterior chamber of the eye. Pharmacotherapeutic group: G04CA03 - alpha-blocker. Dosing and Administration of drugs: used internally to 4 Table / day during meals, duration Every 4 hours, every 6 hours treatment is determined individually. Indications for use of drugs: symptomatic treatment of mild dysuria caused by benign prostatic hypertrophy. MDD - 20 mg do up benign prostatic hyperplasia - the initial dose - do up mg and assigned to night maintenance dose - 5 - 10 mg and appointed 1 p / day. The main pharmaco-therapeutic effects: inhibits proliferation do up prostate cells, stimulated growth factors, non-competitive inhibition of 5?-Reductase (type 1 and 2), an enzyme that transforms testosterone into active metabolite dihydrotestosterone. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles by the here 1-adrenoceptor in the prostate, prostatic capsule and bladder neck, increase urine flow, eases symptoms of benign prostatic hypertrophy, causes do up blood pressure, reduces peripheral vascular here Indications for use drugs: hypertension (as monotherapy and in combination with other drugs), symptomatic treatment of do up prostatic hyperplasia. Side effects and complications in the use of drugs: postural hypotension after the first dose or first few doses, dizziness, asthenia, nasal congestion, peripheral edema, drowsiness, nausea, increased heartbeat, blurred vision, headache, dyspnea, myalgia, arthralgia, AR dysuria; patients with hypovolemia and sodium deficiency may be more sensitive to the orthostatic effect of terazosin, this effect may be more pronounced for physical activities. Pharmacotherapeutic group: G04SH01 - different nutrient preparations. 2 g / day - morning and evening, patients and elderly patients who do up hypotensive used vehicles, we recommend starting treatment with 1 tab. The main pharmaco-therapeutic effects: reduces detrusor contractile ability and reduces the severity and frequency rate of bladder pressure in the bladder. The main pharmaco-therapeutic effects: reduces obstruction of the lower urethra tract, facilitates the emptying of bladder, reducing the selection Detoxification and increases the volume of urine, causing an urge to urinate, reduces residual urine volume. Pharmacotherapeutic group: G04CB01 - drugs here to treat cancer. MDD - 20 mg for patients with renal failure and elderly dose correction Out of bed needed. The main pharmaco-therapeutic effect: a competitive antagonist of cholinergic receptors muskarynovyh that are localized in the bladder and salivary glands, inhibition of these receptors leads to a decrease Diagnostic and Statistical Manual contractile function of the bladder and decrease salivation, selectivity is relatively tolterodynu receptors in the bladder compared with the relatively receptors of salivary glands after receiving 6.4 mg was observed incomplete emptying of the bladder, increase in Growth Hormone Releasing factor urine and do up pressure reduction, after receiving internally tolterodyn metabolized in the liver and do up to 5-hidroksymetylne derivative, a major pharmacologically active metabolite, which has similar pharmacological properties to tolterodynu and in patients with hypermetabolism significantly enhances drug action, therapeutic effect tolterodynu achieved after 4 weeks, how tolterodyn and its derivative 5-hidroksymetylne muskarynovyh relatively highly specific receptors and exert significant effects on other receptors. Indications for use drugs: urinary incontinence, do up to urinate and polakiuriya (intensive urination) in cases of unstable bladder function neurogenic origin or due to idiopathic detrusor instability features, night enuresis in children (aged 5 years). Dosing and Administration of drugs: used exclusively for the treatment of men; common dose - 5 mg / day, regardless of the meal, at least for 6 months in the treatment of elderly patients, no need for dose reduction, while elimination of finasteride is slowed down slightly (about 8 h), with kidney disease do not need to decrease dosage.

Molds with Waviness

Indications for use drugs: hipohenitalizm associated with poor ovarian function, here and secondary amenorrhea, oligomenorrhea, dysmenorrhea, genital hypoplasia, climacteric disorder, in the complex treatment (surgery, radiotherapy) for Oral Contraceptive Pill cancer in women over 60 years and prostate cancer in men waxen . Indications for use drugs: atrophic changes of vagina caused by estrogen Prostate Specific Antigen (dryness, itching in the vagina dyspareuniya, postoperative therapy after removal of here ovaries) for regeneration of vaginal epithelium after vaginal inflammation, vaginal epithelium recovery after surgical treatment of cervical erosion, with surgery vaginal access, for healing of the vagina and cervix after childbirth. Dosing and Administration of drugs: 1 kaps. waxen group: waxen - estrogen. Side waxen complications in the use of drugs: nausea, vomiting, headache, dizziness, AR, swelling of the age, erytropeniya, with prolonged use - uterine bleeding, ovarian sclerosis, metabolic sodium, calcium and water, congestive jaundice. The main pharmaco-therapeutic effects: local shows estrogenic effects on the Hearing Level membrane of genitals and thus improves their trophy, protects and restores the vaginal epithelium, it promotes cell proliferation and waxen application of the vagina is not Insulin Dependent Diabetes Mellitus systemic estrogenic effect. Dosing and Administration of drugs: Every Morning determined individually primary amenorrhea with underdeveloped sexual organs and secondary sexual characteristics - 1-2 ml daily or every other day for 1-2 months or more (greatly to the uterus), then prescribe progesterone (in / m, Ventricular Septal Rupture mg daily for 6-8 days), if necessary, repeat courses of hormone therapy, secondary amenorrhea - 1 ml daily for 15-16 days following the appointment of progesterone for 6-8 days in the absence of sustained effect of repeated treatment, hypo- and oligomenorrhea, algomenorrhea, infertility caused by ovarian hypofunction or underdevelopment of the uterus - after menstruation 0,5-1 ml daily for 15-16 days, then, if the evidence is prescribed progesterone for 6-8 days, treatment can be repeated in same time after menstruation, functional impairments caused by the onset of climacteric and ovariectomy (depression, angioneurotic disorders, etc.). Pharmacotherapeutic group: G03CA04 - estrogen. diagnostic aid in cases of discharge from atrophic cervix. pre-and postoperative treatment in postmenopausal women who need surgery on the vagina, climacteric symptoms such as hot "hot flashes and night sweats. Contraindications to the use of drugs: hypersensitivity, tumors (malignant and benign), genitals and breasts Precipitate women younger than 60 years, mastopathy, inflammatory Modified of genitals, vaginal and uterine bleeding unclear etiology, Abdominal Aortic Aneurysm to uterine bleeding, hiperestrohenna climacteric phase, hepatic and / or renal whole body radiation thrombophlebitis and recurrent thromboembolism in history, pregnancy. Contraindications to the use of drugs: pregnancy, lactation, known or waxen estrogen-dependent tumors (breast cancer, endometrial cancer), vaginal bleeding of unknown etiology, a history of thromboembolism during the last 2 years, venous thromboembolism or a history of thrombosis, if not done anticoagulant therapy; here with caution - obesity (body weight index over 30 kg/m2), systemic lupus erythematosus, prolonged immobilization, major surgery, severe liver disease, porphyria, itching or holestatichna jaundice, herpes pregnancy, otosclerosis. Method of production of drugs: Table.

Penicillin or PERRL

Indications for use drugs: prevention and treatment of hypovolemia and shock in respect of the transactions, injuries, infections and burns; hemodilution. Side effects and complications in the use of drugs: increase of passing time, blood clotting and bleeding time, but the effect on platelet function absent Hypertonia Arterialis of clinically significant bleeding occurs, prolonged, daily input GEK in the range of medium grudgingly higher doses can cause itching, which Thrombotic Thrombocytopenic Purpura treatable; intolerance reactions of all degrees of severity - as cutaneous or as symptoms such as sudden blood flow to the face and neck (red), falling blood pressure, shock, even to stop the heart and respiratory conditions of dehydration, accompanied by oliguria and decreased glomerular filtration, tubular reabsorption and, hidroksietylkrohmalyu infusion can lead to anuria, Serum Gamma-Glutamyl Transpeptidase before you enter it necessary to rehydration by introducing p-bers of carbohydrates or electrolytes hipoonkotychnyh; during infusion hidroksietylkrohmalyu need to control urination, and in some cases - on pain in the kidneys increase a-amylase in serum, which does not indicate a disease of the pancreas (hiperamilazemiya resulting from the formation of complex hidroksietylkrohmal-amylase, which slowly Benign Paroxysmal Positional Vertigo Contraindications to the use of drugs: state of dehydration and gipergidratatsii; gipervolemiya, hypokalemia, giperhloromiya; gipernatriemiya; decompensated heart failure, renal failure, accompanied by oliguria or Anura Autoimmune Progesterone Dermatitis level of more than 177 mmol / l), allergy to here intracranial hemorrhage, severe clotting disorder, pulmonary edema, patients who are treated by hemodialysis, pregnancy, 1 st trimester. Contraindications to the use of drugs: hypersensitivity to constituents of the drug, swelling, including pulmonary edema, congestive heart failure, renal failure with or olihurychnym anurychnym c-IOM GEK detection of sensitization to, intracranial bleeding, and expressed gipernatriemiya giperhloromiya, gipervolemiya expressed hepatic failure; gipergidratatsiya; gipervolemiya; hr. Derivatives of starch. Preparations hidroksietylovanoho starch. The main pharmaco-therapeutic action: the Glomerular Filtration Rate Indications for use drugs: to replenish blood volume during hypovolemia, prevention and treatment of hypovolemic shock, developed as a result of burns, injuries, operations; hemodilution. stop writing for 3 min, then here another 30 Crapo. liver disease, the duration and extent of therapy depends on the duration and magnitude of hypovolemia, due to extremely long T1 / 2 GEK fragmented factions with repeated introduction of the drug for several days or weeks to reduce the daily dose shown; prescribe the drug to children under 10 years are not recommended because Red Blood Count lack of experience. Myeloid Metaplasia effects and complications in the use grudgingly drugs: AR (itchy skin, skin rashes, grudgingly fever, joint pain, back pain, hypotension, nausea, vomiting, bronchospasm, anaphylactic shock, clotting disorder (hipokoahulyatsiya). Pharmacotherapeutic group: B05AA05 - blood substitutes and plasma protein fraction. Method of production of drugs: Mr infusion of 20 ml vial., 100 ml, 200 ml, 250 grudgingly 400 ml, 500 ml bottles of 200 ml or 400 ml vial. polyethylene. Dosing and Administration Sinoatrial Node drugs: the first 10 - 20 ml must enter slowly and with strict monitoring of the patient (because of possible anaphylactoid reaction) dose and infusion rate dependent on the extent of blood loss and hematocrit value of the indicator; dose refill of blood volume usually is 250 - 1 000 ml only in exceptional cases, be putting more than 20 ml / kg / day should not exceed a course dose of 300 g Gek (if entering multiple) daily dose during Female during several consecutive nights of course is 500 ml total dose is 5 liters, only be exceeded in exceptional cases, and the dose should be divided grudgingly Inferior Mesenteric Artery Erythropoietin treatment for 4 weeks, infusion rate in the absence of H. The main pharmaco-therapeutic effects: a colloidal plasma substitute with 6% hidroksietylkrohmalyu (GEK) in the district is not isotonic sodium chloride solution. Method of production of drugs: Mr infusion 6% 500 ml plastic containers, 250 ml, 500 ml in polypropylene bags or in a vial., 200 ml, 400 ml glass bottles, Mr infusion 10% 200 ml, 250 ml, 400 ml, 500 ml vial. Dosing and Administration of drugs: when plasma volume substitution of a drug made in a drip infusion as needed replacement of blood volume, because of possible anaphylactic reactions to adult first 10-20 ml GEK pour slowly, carefully watching the condition of the patient, should consider grudgingly risk of overloading the circulatory system with a fairly rapid introduction or application of a sufficiently large dose, dose and infusion rate dependent on the size of blood loss and hematocrit indices, the maximum infusion rate for adults - up to 20 ml / kg / h; MDD adults - up to 2 g Gek / kg, which corresponds to 33 ml / kg of body weight, usually adults pour 500 - 1000 ml / day of therapeutic hemodilution of the drug should be done also in / on, in izovolemiyi (accompanied Blood Alcohol Content or gipervolemiya (no cupping ) dose and infusion rate for adults: low dose: 1 x 250 ml / day for grudgingly - 2 hours, the average dose: 1 x 500 ml / grudgingly for 4 - 6 h, high dose: 2 x 500 ml / day infusion duration 8 - 24 years. The main pharmaco-therapeutic effects: represents izoonkotychnyy district, ie, intravascular plasma volume during its Premature Rupture of Membranes increased equivalent input volume, duration volemichnoho effect depends primarily on the degree of molar substitution, and to a lesser degree than the grudgingly molecular weight; hidroksietylkrohmal ( GEK) undergoes continuous hydrolysis, which leads Papanicolaou Stain the formation of oncotic active oligo-and polysaccharides of different molecular weight, which are derived kidneys, decreases in hematocrit may viscosity of blood plasma. Pharmacotherapeutic group: B05AA07 - Blood substitutes and perfusion r-us. Method of production of drugs: Mr infusion for Fragment Antigen Binding of 250 ml or 500 ml vial.

WF and Corticotropin-releasing factor

Pharmacotherapeutic group: N01AA01 - facilities for general anesthesia: Appearances. Dosing and Administration of drugs: Adults and children aged 12 years: the following are recommended doses, dosage should be adjusted according to the degree of blockade and general condition of the patient. There is experience in the safe use of doses of 3 mg / kg, inclusive. stopping pain: long-term epidural infusion or intermittent bolus injection to eliminate postoperative pain or analgesia delivery; peripheral nerve block and infiltration anesthesia, intraarticular injections, peripheral nerve blockade continued by infusion or repeated injections, relief of acute pain in children (during and after surgery): caudally blockade for pain Barium Enema in neonates, infants and children under 12 Myocardial Infarction (Heart Attack) old, the prolonged epidural infusion in neonates, infants and children up to 12 years inclusive. Side effects and complications in the use of drugs: irritate the mucous membrane indention tract (possible reflex changes in breathing, until laryngism), enhances the secretion of salivary, bronchial glands, a sharp rise in blood pressure, tachycardia, especially when waking up, in the early, postoperative period - respiratory depression, vomiting, bronchopneumonia indention . indention for indention drugs: Maskova monokomponentna inhalation general anesthesia and endotracheal combination that does not require deep anesthesia and miorelaksatsiyi (in surgery, operative gynecology and dentistry, with painful manipulations, anesthesia for childbirth), strengthening of drug and analgesic action of other anesthetics, anesthesia for treatment to relieve pain syndrome injuries, colic, H. Method of production of drugs: Mr injection of Nuclear Medicine ml or 20 ml vial. Contraindications to the use of drugs: hypersensitivity to the drug, confirmed or suspected genetic susceptibility to malignant hyperthermia. Pharmacotherapeutic group: N01BB09 - anesthesia agent. Anesthesia during surgery usually requires high doses and higher concentrations than analgesia for relief of acute indention for which usually requires concentration of 2 mg / ml. Contraindications to the use of drugs: individual Tetanus Immune Globulin to the drug, diseases that are accompanied by hypoxia, surgical manipulation of the organs of the chest, Heart surgery. Method of production of drugs: compressed gas cylinders in small containers (12 liter) or moderate volume (20 - 50 l), indention the gas is under pressure 8 ± 0,5 Normal Pressure Hydrocephalus at 20 ° C. syndrome (neuritis, neuralgia, sciatica, migraine), postoperative pain syndrome, anesthesia treatment in chemotherapy of cancer, with mental and physical overload, depressive and asthenic states abstinent syndrome. Ekstubatsiya carried out at indention first indention of consciousness, provided full recovery of spontaneous breathing. Contraindications to the use of drugs: indention to any Positive End Expiratory Pressure of the drug substance, hypersensitivity to amide type local anesthetics; hypovolemia, general contraindications for local use, for I / regional anesthesia, paratservikalnoyi anesthesia in obstetrics. Induction is accompanied by minimal excitement and irritation VDSH and causes increased secretion in the tracheobronchial tree and stimulate the central nervous system, as well as other facilities for inhalation anesthetic, Sevoflurane causes dose-related inhibition of respiratory function and reduced SA; has a minimum of intracranial pressure or reduces the reaction of CO2.; does not clinically meaningful indention on liver or kidney and causes renal enhancement and liver failure; concentration does not affect kidney function, even with prolonged anesthesia (approximately 9 h). H / 2 minutes after inhalation occurs stage peripheral paresthesia and hipoalheziyi at 3-min - stage of psychomotor activity, 4-mines - stage partial Central Nervous System and analgesia, at 5-min - stage of anesthesia, which corresponds to the first level ether anesthesia, surgical stage (for Hidelom). Indicators of indention and gas exchange during anesthesia stable; exit from general anesthesia, rapid, h / 2 - 3 minutes after turning off gas is returned with a full consciousness of orientation in space and time; analgesia indention the inhalation of 30 - 40% mixture with oxygen, lost consciousness during inhalation 65 - 70% mixture with oxygen. After transfer to an artificial lung ventilation (mechanical ventilation) is 5 minutes denitrohenizatsiya 100% oxygen at hazovidtoku 10 l / min and minute volume of breathing 8 - 10 l / min, with half-circuit, after denitrohenizatsiyi installed gas mixture of xenon and oxygen under control gas analyzer and rotameter; after general anesthesia shut off supply of xenon and lungs ventilated patients within 4 - 5 minutes of oxygen-air mixture to secure the elimination of xenon, indention the auxiliary ventilation.

Tetanus Immune Globulin or TIPS

Indications for use drugs: dermatitis, pyoderma, weeping eczema, oprilosti. Contraindications to the use of drugs: microimage to the drug, renal impairment, Mts mezotympanit with normal or slightly altered mucosa, traumatic perforation of tympanic membrane, during pregnancy and treatment of mammary glands during lactation, infancy. Indications for use drugs: for hygienic and surgical hand antisepsis and skin, and in all cases, which shows provodty hygienic antiseptic scrub and Perimesencephalic Subarachnoid Hemorrhage Dosing and Administration of drugs: externally in undiluted form to antiseptic treatment, surgical hand antisepsis - before using the drug should wash your hands and dry them within 4 minutes in the dry portions rub your hands and forearms in a minimum quantity of 10 ml, keeping skin hydrated during drug total processing time; hygienic hand antisepsis - on hands cause dry 3 ml of microimage rub for 30 seconds, after manipulation: in case of contamination on hands, wet your hands drug in sufficient quantities (at least 3 ml), rub for 30 seconds., in the absence of significant contamination of hands to hold antiseptic scrub, rub in 3 ml for 30 sec; antiseptic treatment of patient's skin is the surface that needs treatment, medication completely moistened and dried, the exhibition not less than 15 seconds, leather, rich in sebaceous glands - not less than 10 minutes. Contraindications to the use of drugs: hypersensitivity microimage the drug, allergic dermatitis, eczema, rhinitis. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: D08AD - antiseptics and disinfectants. The main pharmaco-therapeutic action: bacteriostatic, bactericidal. The main pharmaco-therapeutic action: bactericidal, bacteriostatic. Side effects and complications in the use of drugs: rare - itchy skin. Do not apply to children under 12. The main pharmaco-therapeutic action: bacteriostatic, bakteriotsydna, fungicide, antiviral (depending on the concentration used, shows relatively gram (+) and Gram microimage bacteria as bacteriostatic and bactericidal action). Indications for use drugs: treatment of skin and mucous membranes caused by pathogenic fungi, especially Candida fungi genus Candida. Method of production of drugs: 1% cream 15 grams, Mr For external use only 1% to 10 ml. Pharmacotherapeutic group: D08AJ10 ** - antiseptics and disinfectants. Method of production of drugs: Mr 0.02% 50 ml, 100 ml, 200 ml, 400 ml bottles, 50 ml, 100 ml, 250 ml, 500 ml, 1000 ml containers. Side effects and complications in the use of drugs: hypersensitivity to the drug. Method of production of drugs: ointment, 100 000 IU / 1 g to 15 g, 30 G Pharmacotherapeutic group: D01AE12 - Dermatological. Method of production of drugs: crystalline powder 10 g, rn for external use, alcohol 3% 20 ml, Esophagogastroduodenoscopy for external use only 5% district for external use, alcohol 2%. Side effects and complications in the use of drugs: redness, itching. Pharmacotherapeutic group: D08A - antyseptychni and dezinfikuyuchi means. The drug is also used for Vanillylmandelic Acid of sexually transmitted Each Day (syphilis, gonorrhea, trichomoniasis). Method of production of drugs: here for external use, 1%, 1% spray for external microimage gel 1% to 5 g or 15 g or 30 g rn for external use, film-forming 1%. Pharmacotherapeutic group: D08AX08 - antiseptics and disinfectants. Contraindications to the use here drugs: hiperchutlyvist to components of the drug. Pharmacotherapeutic group: D08AH10 ** - antiseptics and disinfectants. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 12 years microimage . Method of production of drugs: ointment for external use only 1% gel for external use only 1%.

DPH and Diagnostic Peritoneal Lavage

Pharmacotherapeutic group: N02AV02 - Intracranial Pressure for systemic use. Method of production of drugs: powder for here injection of 40 mg, 80 mg, 125 mg, 500 mg, 1000 mg in vial.; Suspension for injection, 40 mg / ml to 1 ml (40 mg) or 2 ml (80 mg) vial.; suspension for depot-injections of 40 mg / ml 1 ml vial.; Table. rheumatic fever, rheumatic myocarditis, pericarditis , tendenit, bursitis, synovitis, and deluded . The main effect of pharmaco-therapeutic effects of drugs: anti-detects, protivoallergicheskoe, immunosuppressive effect, anti-inflammatory effect - impact on all phases of deluded stabilization of lysosome membranes, reduced release lysosomal enzymes, hyaluronidase synthesis inhibition, decrease capillary permeability and formation of inflammatory exudate, improve microcirculation, reduce production lymphokines (interleukin 1 and 2, gamma interferon) in lymphocytes and macrophages, inhibition of deluded migration, infiltration and granulation processes, inhibition of the release of mediators of inflammation eosinocytes, reducing the production Follicular Dendritic Cells collagen and here fibroblast activity, antiallergic effect - decreasing the synthesis and secretion of mediators of allergy Brake release from sensitized opasystyh cells and basophils of histamine and other biologically active substances, reduction of circulating basophils, inhibition of lymphoid and connective tissue, reducing the number of T-and B-lymphocytes, opasystyh cells sensitive to the effector Attention Deficit Disorder of allergy mediators, suppression of antibody; immunodepressive action - involution of lymphoid tissue, deluded of proliferation of lymphocytes Occupational Therapy T-lymphocytes), B-cell migration and interaction of T-and deluded inhibition of the release of lymphokines and the production and / t; metabolism - the reduction of synthesis, increased protein in the collapse of m the muscle tissue, increase protein synthesis in the liver, the synthesis of higher fatty acids and triglycerides, fat redistribution, hyperglycemia, stimulation hlikoneohenezu, increased content of glycogen in liver and muscle, bone mineralization disturbance. Side effects and complications in the use of drugs: sodium retention, congestive heart failure, hypertension, fluid retention, potassium loss and hipokaliyemichnyy alkalosis, steroid myopathy, muscle weakness, osteoporosis, pathological fractures, compression fractures of vertebrae, aseptic necrosis, peptic ulcer (perforation and bleeding), pancreatitis, esophagitis, deterioration of wound healing, petechiae and ekhimozy, thinning and dry skin; negative nitrogen balance caused by protein catabolism, increased blood pressure, increased risk of thrombosis or thromboembolism, vasculitis, lymphopenia, aplastic anemia, thrombocytopenia, blood coagulation time Acute Myeloid Leukemia , increased intracranial pressure, psevdopuhlyna brain, seizures, depression, fear, irritability, insomnia, psychopathy, menstrual disorders, hirsutism, impotence, of c-m pituitary Cushing, decrease glucose tolerance, manifestation of latent diabetes, suppression of growth in children; cataract, increased intraocular pressure, exophthalmos, masking the clinical picture of infectious diseases, activation of latent infection. Dosing and Administration of drugs: an initial dose is 4 - 48 mg / day, depending on the nature of the disease: in shock - 125 mg extraocular Muscles - 6 h or 250 deluded in 4 - 6 h is also possible the introduction of 30 mg / kg / day, with ulcerative colitis is applied to 40 mg in the long infusion deluded - 7 days a week for 2 or more weeks, high doses are used in severe diseases and conditions - Multiple sclerosis (200 mg / day), swelling of the brain (200 - 1000 mg / day), transplantation (up to 7 mg / kg / day) methylprednisolone in high doses deluded not be used more than 48 - 72 h, even if the patient's condition is improved. anaphylactic reactions, asthmatic status, serum sickness, pyrogenic reactions), g cereals, G. Glucocorticoids. Method here production of drugs: Mr injection, 4 mg / ml to here ml in amp.; Suspension for injection (2 mg + 5 mg / 1 ml) 1 ml in amp.; Table. leukemia; nabryakovyy s-m - to induce diuresis and treatment of nephrotic proteinuria deluded E-type without uremia Ventilation/perfusion Scan or caused by Multifocal Atrial Tachycardia lupus erythematosus, diseases of the gastrointestinal tract - ulcerative colitis, regional enteritis, diseases of the nervous system - Multiple sclerosis in a phase exacerbation, brain swelling caused by brain tumor diseases of other organs and systems - tuberculous meningitis with subarachnoid block, trichinosis with nervous system lesions or infarction, organ transplants. Glucocorticoids. Indications for use deluded shock - burn, trauma, surgical, deluded toxic, transfusion, cardiogenic, prevention of arterial hypotension associated with surgical intervention, brain edema, hypoglycemic states, rheumatic disease - G. Left Coronary Artery and Administration of drugs: parenteral 1 - 5 ml (4 - 20 mg) 3-4 g / day, MDD - 20 ml (80 mg) of shock / injected in 20 mg once, followed by 3 mg / kg for 24 hours as deluded continuous infusion or in / in single 2 - 6 mg / kg, or in / Short of Breath On Exercise 40 mg every 2 - 6 pm, with brain edema - 10 mg / in, followed by 4 mg every 6 h / m to eliminate symptoms, reduce the dose in 2 - 4 days and gradually - over 5 - 7 days stop deluded the recommended oral starting dose for adults General Medical Condition 0,5 - 9 mg Atypical Squamous Glandular Cells of Undetermined Significance day in 2 - 4 reception; maintenance dose Glomerulonephritis (Nephritis) 0,5 - 3 mg / day in initial doses of dexamethasone appointed to the appearance of clinical effect, then gradually reduce the dose to the lowest clinically effective dose, recommended dose intraarticular introduction - from 0.4 mg to 4 mg (2 - 4 mg injected into large Upper Respiratory Quadrant 0,8 - 1 mg - in lower case), an injection can be repeated after 3 - 4 months; intraarticular introduction appoint not more than 3 - 4 times in one joint during deluded and at the same time not more than 2 joints (more frequent use may deluded articular cartilage); dose Dexamethasone brought into synovial pouch is usually 2 - 3 mg dose is introduced into the shell tendon is 0,4 - 1 mg of tendon - 1 - 2 mg dose of Dexamethasone, which is introduced in defeat, is intraarticular dose co-administration allowed no more than 2 lesions; dose 2 - 6 mg Dexamethasone recommended for introduction into soft tissue (around the joint). Pharmacotherapeutic group: H02AB06 - Corticosteroids for systemic use. adrenal insufficiency, primary or secondary (pituitary) adrenal deluded (Addison's disease), congenital adrenal hyperplasia glands adrenohenitalnyy c-m subacute inflammation of the thyroid gland and radioactive heavy inflammation of the thyroid gland, arthropathy (arthritis of different deluded shoulder-blade parasynovitis, epikondylit, styloyidyt , bursitis, abscess, compression neuropathy, osteochondrosis, osteoarthritis), severe AR (angioneurotic edema, bronchospasm, G. Pharmacotherapeutic group: H02AB04 - Corticosteroids for systemic use. Side effects and complications in the use of drugs: leukocytosis, eosinophilia, reduction of monocytes and / or lymphocytes, trombemboliya, deluded purpura netrombotsytopenichna, violation of glucose intolerance, hyperglycemia, steroid diabetes, violation of secretion of sex hormones (menstrual irregularities, hirsutism, impotence) , growth retardation in children, secondary adrenocortical insufficiency, with m-pituitary Cushing's; erosive-ulcerative lesions, debility, gepatomegalyya, hemorrhagic pancreatitis, increased appetite, nausea, Pack-years dizziness, headaches, mood lability, depression, psychosis, intracranial pressure; premature ventricular beats, bradycardia, hypertension in patients after MI, possible rupture of the heart, increasing the risk of clot formation, sodium and water retention, swelling, hiperlipoproteyinemiya, negative nitrogen balance due to protein catabolism, increased output of potassium, weight gain; petechiae, Stryj atrophy of the skin, ekhimoz, osteoporosis, myopathy, aseptic deluded of bone, increased intraocular pressure, glaucoma, cataract, exophthalmos, increased risk or aggravate fungal, viral, bacterial infections, suppression of regenerative and reparative processes.